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ABSTRACT 
Objective: The object of this study was to improve flurbiprofen permeability transdermally using castor oil as penetration enhancer.  
Methods: Castor oil with different concentrations (1%, 2%, 3%, 4%, and 5%) was used in this study as a natural enhancer to improve flurbiprofen 
permeation transdermally as a gel. The formulated gel of the drug was evaluated for several physicochemical characteristics. The in vitro release 
and permeability studies for the drug were performed using Franz cell diffusion apparatus across the synthetic membrane. Korsmeyer Pappas 
kinetic model was used to study the release mechanism of flurbiprofen from the gel. 
Results: The results demonstrated that castor oil was safe with no skin irritation and the formulas were stable over time. Castor oil was 
significantly effective in increasing the percent of flurbiprofen permeability from 46%±2.9 for the gel without enhancer to 95%±2 for the gel with 
5% castor oil and increasing its penetration is directly related to the oil concentration. Two mechanisms for the drug release from the gel were 
involved, which are non-Fickian (anomalous) and super case II transport. 
Conclusion: Flurbiprofen gel was prepared and evaluated successfully for an in vitro parameters with a good permeation across a synthetic 
membrane. The results demonstrated that castor oil had an effective enhancement for permeation of flurbiprofen. 
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Transdermal delivery is a route of administration where active 
ingredients are delivered across the skin for systemic distribution. 
The administration of drugs through the skin has benefits in 
comparison with oral administration. It is a non-invasive 
administration and suitable for people who cannot administer 
drugs orally (unconscious or suffering vomiting). Also, 
gastrointestinal side effects and the first-pass metabolism can be 
avoided [1-5]. Flurbiprofen is a member of the phenyl alkanoic 
acid derivative of non-steroidal anti-inflammatory drugs (NSAIDs) 
family. Oral flurbiprofen exhibits low bioavailability since it is a 
class II drug according to biopharmaceutical classification system, 
has low aqueous solubility. Therefore, to improve its bio-
availability, the drug formulated as a transdermal gel. The 
absorbed drug appears to be adequate for therapeutic uses in spite 
of its amount required for therapeutic effect in transdermal drug 
delivery system is less bioavailable as compared to the oral route 
of administration [6]. The gel is a solid jelly-like material that can 
have properties ranging from soft and weak to hard and tough. It is 
a network of polymer chains that are hydrophilic, sometimes 
found as a colloidal in which water is the dispersion medium, it 
can contain more than 90% water. It is highly absorbed synthetic 
or natural polymeric networks. It also possesses a degree of 
flexibility very similar to natural tissue due to their significant 
water content. Drug penetration via transdermal route can be 
improved using penetration enhancers [6-8]. 
Numbers of literature contain reports using different material 
which used as penetration enhancers. There are different 
mechanisms for the enhancement of these substances, and they 
are classified according to their chemical structure. This 
classification is out of practical assistance since they improve 
penetration through the skin by different mechanisms that may 
not be straightforward to illustrate. Depending on the enhancer 
physicochemical properties, substances which belong to the same 
group may have different mechanisms of enhancement. Most of 
the effective enhancers are a surfactant which has a deteriorating 
effect on the living cell for long-term use. Almond and olive oil are 
natural oils and have been used as skin penetration enhancers in 
various concentrations which significantly enhance the drug 
permeation transdermally [7, 9, 10]. As a gel formulation, drugs 
can be trapped within polymers network then released by 
diffusion based on zero order kinetic. The rate of drug release and 
diffusion kinetics from gel are determined by the drug-polymer 
interaction, the intrinsic properties of the gel, drug solubility and 
the amount of entrapped drug [11]. 
The study aimed to investigate the efficacy and safety of castor oil as 
a permeation enhancer on the permeability of flurbiprofen from the 
transdermal gel using Franz cells.  
MATERIALS AND METHODS  
Materials 
Flurbiprofen was purchased from FAC limited (India), Carbopol 940 
was bought from Sigma Chemicals (USA). Castor oil was provided 
from Hemani live natural (Pakistan). Triethanolamine (TEA) was 
purchased from Merck (Germany). Franz cell was bought from SES 
GmbH (Germany). 
Method 
Preparation of flurbiprofen hydrogel 
The gel was developed by dispersing carbopol 940 (2%) in a 
sufficient amount of distilled water and stirred till a homogeneous 
dispersion obtained. Flurbiprofen (1%) was dissolved in a suitable 
volume of 96% ethanol and sonicated to get a solution. The drug 
solution was added to carbopol 940 dispersion drop-wise and was 
stirred continuously. Castor oil was added in different 
concentrations to 5 different formulas; leaving one without the oil, 
being the control and the others containing different amount of the 
enhancer of 1%, 2%, 3%, 4%, and 5%. A solution of 
triethanolamine (TEA) was added drop-wise (Up to 1%) for all 
formulas and mixed. The final volume of the gel was up to 40 ml 
adding the required volume of distilled water and stirred to get a 
homogenous gel [10, 12-14].  
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Evaluations of flurbiprofen hydrogel 
Organoleptic characteristics 
They include the products liquefaction, color, phase separation and 
homogeneity which were investigated by visual inspection at 
various intervals at 1st, 2nd, 5th, 10th, 20th, 30th, and 50th d. 
Skin irritation test 
It was performed by applying 1 g of the formula of gel on the hand to 
a 2 square inch area near the wrist and was observed for any lesions, 
irritation, stinging or redness, the number of volunteers was ten 
patients [10, 13]. 
pH changes 
The pH of different gel formulations was checked using pH meter 
Hanna (USA) at 1st, 3rd, 7th, 12th, 19th, 21th, 28th, 40th, and 50th d after 
formulation. 
Drug content 
An amount of 100 mg of the formulated gel for each formula was 
separately dissolved in 100 ml of phosphate buffer pH 7.4 stirred for 
sufficient time to get completely soluble and filtered by syringe filter 
of 0.45 mm pore size. The concentration of flurbiprofen was 
measured spectroscopically using the regression equation of the 
drug calibration curve in 7.4 phosphate buffer at 274 nm [15]. 
Viscosity 
The viscosity of the formulated gel was assisted using Brookfield 
viscometer at 37 °C. The apparatus spindle was rotated 10 rpm. The 
mean of three readings has been calculated to determine gel 
viscosity. 
In vitro drug permeability and release kinetic study  
Castor oil effect as a permeation enhancer on flurbiprofen 
penetration through the synthetic membrane was studied using 
Franz diffusion cell. The receptor compartment was filled with 
phosphate buffer solution of pH 7.4. A receptor cell volume of 5 ml 
and the effective diffusional surface area of 0.8 cm2. The membrane 
was fixed between the donor and receptor compartment of Franz 
diffusion cell apparatus. A quantity of 1 g of the prepared gel 
formulas installed in the donor compartment. The medium was 
stirred at 100 rpm, and the temperature of the cell was maintained 
at 37 °C. The samples of 2 ml were drawn from the receptor 
compartment at specified intervals then replaced with an equal 
volume of the fresh buffer to keep the sink conditions. The 
flurbiprofen amount in the drawn samples was qualified 
spectroscopically using the regression equation of the drug 
calibration curve in 7.4 phosphate buffer at 274 nm [13]. The drug 
release mechanism was determined using Korsmeyer Pappas kinetic 
model. The in vitro flurbiprofen mechanism of release was found 




Where Mt/M∞ is the fractional drug release from the gel into the 
receptor media, K is a flurbiprofen delivery constant whereas (n) is 
diffusion coefficient and its value indicates the mechanism of the 
drug release in the solvent. The (n) value of 0.5 that indicates Quasi-
Fickian diffusion mechanism, while if (n>0.5) then anomalous or 
non-Fickian diffusion mechanism exists and if it is (=1) then the Zero 
order release one exists [11]. 
Flurbiprofen-other additives compatibility study 
The drug and other excipients compatibility were conducted using 
Fourier-transform infrared spectroscopy (FTIR). The FTIR spectrum 
of the pure drug was compared with the spectra of the optimum 
formula physical mixture to identify drug-excipient compatibility. 
Statistical analysis 
Statistical analysis was carried out using one-way analysis of 
variance (ANOVA). The difference is considered statistically 
significant when p<0.05. 
RESULTS AND DISCUSSION 
Evaluation of prepared flurbiprofen hydrogel 
General characteristics of formulated gels 
All characterization properties of the prepared flurbiprofen 
hydrogel such as the color, liquefaction, phase separation, and skin 
irritation test have been evaluated. The results indicate good 
physical stability of the all formulated gels since there were no 
liquefaction, color change or phase separation along 50 d from the 
time of gel formulation. There was no skin irritation in the applied 
area of the volunteers, and this indicates the formulated gels are 
suitable for human skin. The gel color was white for all formulations, 
and that color was stable along the period of evaluation. The drug 
content of the flubiprofen gel formulas was between 94.7%±2.1 and 
98%±1.2 demonstrated a good content uniformity for the prepared 
formulas [15-19]. The viscosity of the formulas decreased with 
increasing enhancer concentration. It was between 17850 cP to 
15935 cP (table 1) [20]. 
 
Table 1: The drug content of the gel formulations of flurbiprofen 1% (w/v), the results represent mean±SD (n = 3) 
Formulas Castor oil Viscosity (cP) at 10 rpm Drug content 
F1 0% 19850±45 98%±1.2 
F2 1% 18623±15 95.1%±1.9 
F3 2% 18173±19 97%±1.5 
F4 3% 17862±42 96%±1.1 
F5 4% 17528±37 94.7%±2.1 
F6 5% 17182±23 95.4%±1.6 
*The gel formulas containing 1% flurbiprofen, 2% carpabol 940, TEA, and the stated concentration of castor oil. 
 
pH changes 
The pH of gel formulas was measured using pH meter (fig. 1). All the 
formulas were safe, stable, and did not irritate since their pH was 
within the normal skin pH range (4 to 7) and there is no significant 
difference throughout storage time of the formulas [19]. 
In vitro drug permeability and release kinetics  
The flurbiprofen release from the gel through the membrane (Franz cell) 
explained in fig. 2. It is found that the gel formulation without 
penetration enhancer had the lowest percentage of the drug permeation 
of 47% after 24 h. However, adding castor oil to the gel significantly 
(P<0.05) improved the drug penetration. The percent of flurbiprofen 
penetration reached to 79% adding 1% enhancer to the gel, and the drug 
permeation was significantly (P<0.05) raised with increasing castor oil 
concentration reaching 81% from the gel of 2% castor oil. Moreover, 
85%, 88% and the maximum percentage of the release 95% were 
obtained by adding 3%, 4%, and 5% of castor oil, respectively.  
In comparison with other studies used oils (almond and olive oil) as 
permeability enhancers, the results showed the same enhancing ability 
for ketoprofen and flurbiprofen transdermally [9, 10, 13]. That is 
because of the ability of castor oil to enhance the diffusion of the drug 
by modifying the barrier characteristics of the membrane and could be 
the stratum corneum. Carbopol 940 was used in the formulation of the 
gel to control the release rate of flurbiprofen up to 24 h since it is a 
controlling rate polymer [17, 21, 22]. 
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Fig. 1: The pH value of flurbiprofen formulated gel with time of storage, all the values represent by mean pH±SD, where F1 formula is the 
gel without castor oil (control) and F2, F3, F4, F5, and F6 containing 1%, 2%, 3%, 4%, and 5% castor oil respectively. (n = 3) 
 
 
Fig. 2: Percentage of flurbiprofen permeated across synthetic membrane in pH 7.4 buffer, this study was performed using Franz cell, all 
the values represent by mean percent of the drug permeated±SD,where F1 formula is the gel without castor oil (control) and F2, F3, F4, 
F5, and F6 containing 1%, 2%, 3%, 4%, and 5% castor oil respectively. (n=3) 
 
The release kinetics of the gel was determined by applying 
Korsmeyer Pappas model on flurbiprofen penetration profiles from 
the formulated gel. As mentioned above an (n) value in this release 
kinetic model equation is the way of the drug releasing from the gel 
across the membrane into the receptor media. The (n) values of the 
model were 1<n>0.5 revealing that two mechanisms for the drug 
release from the gel were involved, which are non-Fickian 
(anomalous) and super case II transport (table 2) [11, 22, 23]. 
 
Table 2: Korsmeyer-peppas kinetic model for flurbiprofen penetration through the synthetic membrane, where the F1 formula is the gel 
without castor oil (control) and F2, F3, F4, F5, and F6 containing 1%, 2%, 3%, 4%, and 5% castor oil respectively 
Formulas R2 n-value Type of release 
F1 0.9119 0.8314 Non-Fickian diffusion  
F2 0.9353 1.1708 Super case-II transport 
F3 0.929 1.0924 Super case-II transport 
F4 0.9226 1.0219 Super case-II transport 
F5 0.9326 1.0604 Super case-II transport 
F6 0.9424 1.058 Super case-II transport 
 
Compatibility study 
The FTIR spectra (fig. 3) demonstrated no significant change of 
pure flurbiprofen peaks and the gel mixture.  
Therefore, there was no interaction between the drug and the 
gel component ingredients. The characterized broad peaks of 
flurbiprofen at 1656, and 2934 cm−1 were present because of 
the drug carbonyl and hydroxyl group stretching. These two 
fingerprint groups’ peaks of the drug had been shown in the gel 
mixture spectrum. However, the spectrum of the gel mixture 
shows broad peak 3400 to 1700 cm−1 due to hydrogen bond 
[24-26]. 
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Fig. 3: FTIR spectra of flurbiprofen and the gel formulations additives, where (A) represents pure drug spectrum, while (B) flurbiprofen 
and gel ingredients mixture 
 
CONCLUSION  
Flurbiprofengel was prepared and evaluated successfully for an in 
vitro parameters with a good permeation across the synthetic 
membrane. The results demonstrated that castor oil had an effective 
enhancement for permeation of flurbiprofen. The gel formulations 
with the higher concentration of the oil were significantly (P<0.05) 
enhanced penetration of the drug through the membrane which 
indicates that there are two release mechanisms for flurbiprofen 
from the gel, including non-Fickian and super case II transport. 
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